EIDOS THERAPEUTICS INC's ticker is EIDX and the CUSIP is 28249H104. A total of 91 filers reported holding EIDOS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 0.74 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,123,000 | +5.1% | 22,234 | -0.7% | 0.00% | 0.0% |
Q2 2020 | $1,068,000 | -26.2% | 22,400 | -24.2% | 0.00% | -40.0% |
Q1 2020 | $1,447,000 | -10.9% | 29,540 | +4.4% | 0.01% | 0.0% |
Q4 2019 | $1,624,000 | +257.7% | 28,301 | +93.7% | 0.01% | +400.0% |
Q2 2019 | $454,000 | – | 14,609 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aisling Capital Management LP | 1,123,630 | $56,777,000 | 18.14% |
Board of Trustees of The Leland Stanford Junior University | 265,670 | $13,425,000 | 5.17% |
Opaleye Management Inc. | 315,550 | $15,945,000 | 3.12% |
RA Capital Management | 2,163,271 | $109,310,000 | 2.00% |
Cormorant Asset Management, LP | 993,185 | $50,186,000 | 1.93% |
Parkman Healthcare Partners LLC | 41,091 | $2,076,000 | 0.55% |
Perceptive Advisors | 686,922 | $34,710,000 | 0.51% |
Redmile Group, LLC | 466,205 | $23,557,000 | 0.43% |
Eventide Asset Management | 317,417 | $16,039,000 | 0.31% |
Ikarian Capital, LLC | 63,011 | $3,184,000 | 0.23% |